This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

​​Australia's iNova, Juno PC deal sparks probe into market for phentermine weight-loss drugs

By James Panichi ( September 3, 2019, 03:15 GMT | Insight) -- The proposed acquisition of Australian pharmaceutical joint venture Juno PC by iNova Pharmaceuticals has prompted the country’s competition regulator to focus its review of the deal on the market for prescription weight-loss medication that contains phentermine as an active ingredient. In releasing its market inquiries letter this week, the Australian Competition & Consumer Commission said that it would focus its probe on the extent to which iNova and Juno PC’s products compete and whether a generic phentermine hydrochloride product is likely to commence supply in Australia.The proposed acquisition of Australian pharmaceutical joint venture Juno PC by iNova Pharmaceuticals (Australia) has prompted the country’s competition regulator to focus its review of the deal on the market for prescription weight-loss medication that contains phentermine as an active ingredient....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login